Lyon, France

Sébastien Ladet

This inventor holds 50 USPTO granted patents and 8 published patent applications, plus 8 CIPO patents and 31 EPO patents, primarily in Tissue Repair Implants. Top assignees: Sofradim Production, Covidien LP. Active years: 2013-2026.

USPTO Granted Patents = 50 

% Patents Active = 66.0

 

 

Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 1,266(Granted Patents)


Location History:

  • Lyons, FR (2013 - 2018)
  • Caluire et Cuire, FR (2014 - 2018)
  • Caluire & Cuire, FR (2015 - 2023)

Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Hernia Prosthesis
Tissue Repair
Chitosan
Surgical Adhesives
Biocompatible Compounds
Porous Layer
Surgical Fasteners
Composite Mesh
Therapeutic Agents
Bioresorbable Materials
Functional Adhesives
3D Mesh
50 patents (USPTO):Explore Patents

Title: Sébastien Ladet: Pioneering Inventor from Lyons, FR

Introduction: Sébastien Ladet is a renowned inventor hailing from Lyons, France, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Sébastien Ladet holds several patents in the areas of renewable energy technologies, sustainable transportation solutions, and advanced materials science.

Career Highlights: With a career spanning over two decades, Sébastien Ladet has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Sébastien Ladet has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, resulting in successful products and solutions that have had a lasting impact on society.

Conclusion: Sébastien Ladet's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs around the globe.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…